AnaptysBio
ANAB
ANAB
116 hedge funds and large institutions have $615M invested in AnaptysBio in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.18M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less capital invested
Capital invested by funds: $675M → $615M (-$60.4M)
Holders
116
Holding in Top 10
2
Calls
$1.2M
Puts
$1.18M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$6.55M | |
| 3 | +$3.69M | |
| 4 |
Millennium Management
New York
|
+$2.79M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.83M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$4.78M | |
| 3 | -$4.5M | |
| 4 |
JP Morgan Chase
New York
|
-$3.79M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$2.64M |